CYP2A6 and coronary artery disorder: Previous studies reported a higher prevalence (62.2%) of WT CYP2A6 allele gene in CAD patients, both in smoker and nonsmoker groups,[12] while in our study, all CAD patients were active smokers, with ~60% WT and ~40% mutant alleles.